In the event that the FDA later approves the Wegovy pill, or similar GLP-1 pills under development, the initial dose of those drugs will be priced at $150 per month
Future outlook Research into GLP-1 patches is progressing quickly, with several pharmaceutical companies reporting positive results from preclinical and early human studies
7 Recently, a retrospective review of over 16,000 patients presenting to a tertiary neuro-ophthalmology practice showed a potential link between semaglutide and NA-AION
Campbell P, Rutten FH, Lee MM, Hawkins NM, Petrie MC
Assuming rebates of 50% across all GLP-1 products in 2024 would mean net spending of around $14 billion in 2024
The scientific evidence supporting their ability to raise GLP-1 levels or lead to substantial weight loss is limited at best